|
|
||||||||
RESEARCH REPORT |
1 St. Louis University Center for Advanced Dental Education, Department of Endodontics, St. Louis, MO; and
2 Southern Illinois University School of Dental Medicine, Department of Applied Dental Medicine, 2800 College Ave., Alton, IL 62002;
*corresponding author, rzachow{at}siue.edu
| ABSTRACT |
|---|
|
|
|---|
-dihydrotestosterone did not affect, AR mRNA content. ERß was not hormonally altered in pulp cell cultures. By showing steroid- and cytokine-orchestrated regulation of AR mRNA in vitro, it is possible that age- and/or pathogen-dependent changes in available steroids and cytokines can affect any androgen-responsiveness of pulp.
KEY WORDS: androgen receptor androgen hepatocyte growth factor estrogen tooth pulp
| INTRODUCTION |
|---|
|
|
|---|
Although hormonal regulation of human odontoblast function has not been directly shown in vivo, fluctuations in steroid hormone and cytokine levels do affect dental health, as evidenced by (1) the apparent androgen-dependence of tooth morphogenesis during human development (Molsted et al., 1997), (2) progestin-correlated changes that occur in the oral cavity during pregnancy (Ojanotko-Harri et al., 1991), and (3) compromised dentition resulting from the menopausal-associated loss in ovarian estradiol-17ß (E2) production (Krall et al., 1997). Moreover, altered patterns of dentin apposition have been reported in teeth from ovariectomized rats (Hietala and Larmas, 1992). Although the precise steroid hormone-dependent mechanisms that may mediate the aforementioned processes are debatable, the similarities between tooth and bone tissues can be used to develop a model in which steroid hormones and cytokines support tooth integrity by modulating odontoblast activity.
Steroid hormone bioactivity is controlled at the cellular level via the activation of steroid hormone receptors. Upon an elaborate activation scheme, steroid hormone receptors mediate the transcription of steroid-responsive genes. Isoforms of the estrogen receptor (ER
and ERß) have been identified in human osteoblasts (Byers et al., 2001); and while ER
appears to mediate the anti-osteoporotic actions of E2 in human bone (Ericksen and Mosekilde, 1990), the function of ERß is uncertain. In addition, androgens, via the activation of osteoblastic androgen receptors (AR) (Wiren et al., 1997), appear to support E2 in thwarting age-associated osteoporosis (Rosenberg et al., 1997). Of particular interest is the observation that cytokines (e.g., HGF, interleukins, tumor necrosis factor-
, and transforming growth factor-ß) regulate the steroid hormone-responsiveness within bone (Spelsberg et al., 1999), perhaps by modulating the level of steroid hormone receptor expression (Jilka, 1998).
The complement of steroid hormone receptors in human tooth pulp is uncertain, because contradictory data have been presented thus far. For example, immunoreactive ER was shown in pulp tissue (Hietala et al., 1998); whereas, in a separate study, immunoreactive progesterone receptor was identified in pulp tissue, but neither AR nor ER was detected (Whitaker et al., 1998). Thus, it appears that human tooth pulp contains steroid hormone receptors, and pulp tissue would therefore be steroid-responsive. The present study extends this concept by identifying AR and ERß mRNAs in human tooth pulp. In addition, the effects of androgens, E2, and HGF on AR mRNA content in pulp cells were investigated in vitro.
| MATERIALS & METHODS |
|---|
|
|
|---|
For cell culture, pulp was placed in M199 and minced. The minced pulp tissue was enzymatically dissociated in a collagenase/deoxyribonuclease cocktail as previously described (Magoffin and Erickson, 1988). Enzymatic dispersal was conducted for up to 60 min in a 37°C Dubnoff shaking H2O bath. The enzymatic dissociation was terminated by the addition of an excess volume of ice-cold McCoy's 5A medium (M5A, Gibco) with added antibiotics and 1% FCS. The pulpal cell suspension was centrifuged for 5 min at 450 x g (4°C), and the pellet was re-suspended in a known volume of M5A. Cell viability and number were determined by means of a hemacytometer following a challenge with trypan blue.
Cells (1-2 x 105 viable cells/well/500 µL M5A) were pipetted into 24-well culture plates. Cultures were incubated at 37°C in a H2O-saturated atmosphere containing 5% CO2 in air. Following an overnight acclimation period, cell-conditioned media were discarded, and cells were given fresh, pre-warmed (37°C) M5A. The cells were then challenged with androstenedione (0.1, 1, 10 µM), E2 (0.01, 0.1, 1 µM), 5
-dihydrotestosterone (DHT; 0.1, 1, 10 µM), testosterone (0.1, 1, 10 µM), or recombinant human HGF (1, 10, 30 ng/ml; R&D Systems, Minneapolis, MN, USA). We chose steroid hormone concentrations to bracket the serum levels of these hormones in reproductive-age men and women (Williams, 1981). We chose the HGF doses to bracket the reported dissociation constant Kd (24-32 pM) for HGF binding to c-Met (Higuchi and Nakamura, 1991).
RT-PCR
Total RNA was extracted from the pulp cells by means of TriReagent and Microcarrier (Molecular Research Center, Inc., Cincinnati, OH, USA), according to the manufacturer's protocol. Upon purification, RNA was re-suspended in RNase-free H2O, and RNA concentration was measured at A260.
The relative abundances of target gene mRNAs were determined by semi-quantitative RT-PCR based upon the method previously described (Orly et al., 1994). Approximately 1 µg RNA/reaction were used as the template for the synthesis of cDNA in a cocktail containing 1 x PCR buffer II (PE Applied Biosystems, Hercules, CA, USA), 0.5 mM dNTP, 100 ng oligo dT16, 1 U/µL recombinant placental RNase inhibitor, 200 U MuLV reverse transcriptase, and 4 mM MgCl2. After incubation at 37°C for 30 min, the reaction was heat-inactivated at 95°C for 5 min, and then cooled to 22°C. The cDNA products were then divided for the subsequent amplification of AR, ERß, ER
, c-Met, and GAPDH in separate PCR procedures. Specific cDNA primers (10-50 pmol) for human AR, ERß, ER
, and c-Met were used during PCR as previously described (Takeuchi et al., 1994; Hillier et al., 1998; Osuga et al., 1999). Each reaction also contained 1 µCi of
-32P-dCTP and 0.5 U AmpliTaq Gold polymerase in 1 x PCR Buffer II. Gene-specific cycles of PCR were run as follows for AR, ERß, ER
, and c-Met: 95°C for 12 min, followed by 35 cycles at 95°C (1 min), 54°C (1 min), and 72°C (1 min). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was amplified during 23 cycles at the above temperatures and times. All PCR reactions were terminated with a 10-minute extension phase at 72°C. The gene-specific PCR cycles were chosen based upon preliminary experiments in which the linear phase of amplification was determined (data not shown). All RT-PCR reactions included a negative control in which no RNA was added, and the absence of DNA contamination was determined in PCR reactions that were conducted in the absence of reverse transcriptase.
Amplification of a specific 414-bp region of cDNA for GAPDH (Wiren et al., 1997) was conducted as an internal control for differences in total RNA concentration among samples, and variability among individual PCR amplifications.
All PCR products were visualized in 2% agarose gels stained with ethidium bromide. Scanned gel images were digitally analyzed with the use of the Kodak 1D Image Analysis software program (version 3.0). The relative mRNA abundance is presented in this study as the ratio of target gene/GAPDH.
Statistical Analysis
For in vivo studies (freshly isolated pulp), data from pulp samples were grouped according to gender and age. We analyzed the data by comparing age groups (16-20, 21-35, and 36-45) within and among men and women. In all experiments, mean values from independent experiments were analyzed by unpaired t test, and multiple comparisons were performed by one-way Analysis of Variance followed by Tukey's analysis. Values were determined to be significant when P
0.05.
| RESULTS |
|---|
|
|
|---|
was not detected in freshly isolated pulp tissue or in pulp cell cultures.
|
|
When compared with control cells at 24 and 48 hrs, testosterone, at all concentrations tested, caused a significant decline in the control levels of AR mRNA (Fig. 2c
). In contrast, DHT did not significantly alter the relative abundance of AR mRNA at 24 hrs (not shown) and 48 hrs (Fig. 2d
).
Cytokine Regulation of Pulpal AR Expression: HGF and c-Met
At 48 hrs, pulp cells were screened by RT-PCR for the presence of c-Met mRNA. A single band representing the predicted 222-bp c-Met amplicon was visualized, and a representative gel is shown in Fig. 4a
.
|
| DISCUSSION |
|---|
|
|
|---|
Interestingly, both the non-anabolic androgen, androstenedione, as well as the predominant estrogen, E2, stimulated an increase in AR mRNA expression in vitro. In contrast, the anabolic gonadal androgen, testosterone, caused a significant reduction in AR content in pulp cells; whereas the more potent androgen, DHT, did not alter AR expression. The regulation of AR expression by androgens and E2 has not been previously reported in dental tissues; however, this regulatory mechanism is not without precedent, as demonstrated in osteoblasts, human prostatic cells, and adipocytes in vitro (Wiren et al., 1997; Blanchere et al., 1998; Dieudonne et al., 1998). Analysis of the present data indicates that fluctuations in the predominant gonadal androgens (androstenedione and testosterone) and E2 can affect pulpal responsiveness to androgens via changes in the expression of AR. Unlike the effects of androstenedione and testosterone, DHT did not alter the relative level of AR mRNA in vitro. To conceptualize this apparent paradox, one must consider that the steroid pathway enzymes, 17ß-hydroxysteroid dehydrogenase (17ß-HSD) and cytochrome P450 aromatase (P450arom), can convert (i.e., aromatize) androstenedione and testosterone into estrogens; whereas DHT is a non-aromatizable androgen. The presence of pulpal P450arom and 17ß-HSD has not been reported to our knowledge; however, if these enzymes are present, the observed effects of androstenedione and testosterone could result from AR- and/or ER-mediated events; whereas any steroid hormone-dependent actions of DHT would be mediated by AR. This is probably a simplistic interpretation, because numerous signaling mechanisms, including cross-talk among steroid hormone receptors, can influence steroid hormone receptor function (Beato and Klug, 2000). Therefore, it is plausible that complex signaling arrays mediate any androgen- and estrogen-dependent changes in AR expression in pulp cells.
Although E2 increased AR mRNA content in pulp cells, and ERß mRNA was detected in these cells, the hormones that were tested failed to induce measurable changes in ERß content in vitro. These data do, however, lend further support to a mechanism in which gonadal steroidogenesis is coupled to pulp function at two levels: (1) direct effects of androgens and E2 via activation of AR and/or ERß, and (2) a feedback loop in which androgens and E2 control AR expression in pulp cells, thereby regulating the (proposed) androgen-responsiveness of this tissue.
While ERß mRNA was detected in human pulp tissue, ER
expression was not established. At this time, the presence of ER
in pulp cells cannot be excluded; however, we suggest that the RT-PCR procedure is an extremely sensitive technique for the detection of mRNA. Thus, if pulp tissue indeed expresses the ER
isoform, it is possible that functionally significant levels of ER
may be expressed in response to exquisite temporal and/or hormonal mechanisms that were not tested in this study.
It is important to consider that cytokine and steroid hormone interactions have been documented with regard to bone development and maintenance (Spelsberg et al., 1999). Since HGF has morphogenic actions in dental tissues (Kajihara et al., 1999) and is secreted by pulp (Ohnishi et al., 2000), the effect of HGF on AR expression in pulp cells was tested. This report showed that (1) the HGF receptor, c-Met, is expressed in pulp cells, and (2) HGF up-regulated the relative abundance of AR mRNA in pulp cell cultures. By promoting AR expression, we suggest that HGF, via c-Met-directed signaling, increases pulpal sensitivity to androgens. Thus, any effect of androgens in pulp tissue would be indirectly supported by HGF. Although osteoblastic HGF can regulate certain aspects of bone remodeling and repair (Grano et al., 1996), the parallel effects of odontoblastic HGF in dental tissue (e.g., stimulating dentinogenesis) remain speculative pending further research.
|
| ACKNOWLEDGMENTS |
|---|
Received June 15, 2001; Last revision January 22, 2002; Accepted February 28, 2002
| REFERENCES |
|---|
|
|
|---|
Blanchere M, Berthaut I, Portois MC, Mestayer C, Mowszowicz I (1998). Hormonal regulation of the androgen receptor expression in human prostatic cells in culture. J Steroid Biochem Mol Biol 66:319326.[Medline]
Byers RJ, Hoyland JA, Braidman IP (2001). Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 168:353362.[Abstract]
Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y (1998). Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645C1652.
Ericksen E, Mosekilde L (1990). Estrogen and bone. J Bone Min Res 7:273301.
Fuller K, Owens J, Chambers TJ (1995). The effect of hepatocyte growth factor on behaviour of osteoclasts. Biochem Biophys Res Commun 212:334340.[Medline]
Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, Zallone AZ, et al. (1996). Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA 93:76447648.
Hietala E, Larmas M (1992). The effect of ovariectomy on dentin formation and caries in adult rats. Acta Odontol Scand 50:337343.[Medline]
Hietala EL, Larmas M, Salo T (1998). Localization of estrogen receptor-related antigen in human odontoblasts. J Dent Res 77:13841387.
Higuchi O, Nakamura T (1991). Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. Biochem Biophys Res Commun 176:599607.[Medline]
Hillier SG, Anderson RA, Williams ARW, Tetsuka M (1998). Expression of estrogen receptor
and ß in cultured human ovarian surface epithelial cells. Mol Human Reprod 4:811815.
Jilka RL (1998). Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone 23:7581.[Medline]
Kajihara T, Ohnishi T, Arakaki N, Semba I, Daikuhara Y (1999). Expression of hepatocyte growth factor and c-Met in human dental papilla and fibroblasts from dental papilla. Arch Oral Biol 44:135147.[Medline]
Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergedal J (1990). Studies of the mechanisms by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Met 71:13221329.[Abstract]
Khosla S, Spelsberg TC, Riggs BL (1999). Sex steroid effects on bone metabolism. In: Dynamics of bone and cartilage metabolism. San Diego: Academic Press.
Krall EA, Dawson-Hughes B, Hannan MT, Wilson PW, Kiel DP (1997). Postmenopausal estrogen replacement and tooth retention. Am J Med 102:536542.[Medline]
Magoffin DA, Erickson GF (1988). Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 122:23452347.[Abstract]
Molsted K, Kjaer I, Giwercman A, Vesterhauge S, Skakkebaek NE (1997). Craniofacial morphology in patients with Kallman's syndrome with and without cleft lip and palate. Cleft Palate Craniofac J 34:417424.[Medline]
Ohnishi T, Suwa M, Oyama T, Arakaki N, Torii M, Daikuhara Y (2000). Prostaglandin E2 predominantly induces production of hepatocyte growth factor/scatter factor in human dental pulp in acute inflammation. J Dent Res 79:748755.
Ojanotko-Harri AO, Harri MP, Hurttia HM, Sewon LA (1991). Altered tissue metabolism of progesterone in pregnancy gingivitis and granuloma. J Clin Periodontol 18:262266.[Medline]
Orly J, Rei Z, Greenberg NM, Richards JS (1994). Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 134:23362346.[Abstract]
Osuga Y, Tsutsumi O, Momoeda M, Okagaki R, Matsumi H, Hiroi H, et al. (1999). Evidence for the presence of hepatocyte growth factor expression in human ovarian follicles. Mol Hum Reprod 5:703707.
Rosenberg MJ, King TDN, Timmons MC (1997). Estrogen-androgen for hormone replacement. J Reprod Med 42:394404.[Medline]
Spelsberg TC, Subramaniam M, Riggs BL, Khosla S (1999). The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13:819828.
Takeuchi M, Kakushi H, Tohkin M (1994). Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. Biochem Biophys Res Commun 204:905911.[Medline]
Trowbridge HO, Kim S (1998). Pulp development, structure, and function. In: Pathways of the pulp. Cohen S, Burns R, editors. St. Louis: Mosby, pp. 386-424.
Whitaker SB, Singh BB, Weller RN, Bath KR, Loushine RJ (1998). Sex hormone receptor status of the dental pulp and lesions of pulpal origin. Oral Surg Oral Med Oral Radiol Endod 87:233237.
Williams RH (1981). Textbook of endocrinology. 6th ed. Philadelphia: W.B. Saunders.
Wiren K, Zhang X, Chang C, Keenan E, Orwoll E (1997). Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. Endocrinology 136:22912300.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |